Walter V. Klemp - Jul 2, 2021 Form 4 Insider Report for Moleculin Biotech, Inc. (MBRX)

Signature
/s/ Walter V. Klemp
Stock symbol
MBRX
Transactions as of
Jul 2, 2021
Transactions value $
-$12,759
Form type
4
Date filed
7/6/2021, 07:30 AM
Previous filing
Jun 21, 2021
Next filing
Jul 12, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MBRX Common Stock Options Exercise +14.7K +8.59% 186K Jul 2, 2021 Direct F1
transaction MBRX Common Stock Tax liability -$12.8K -3.58K -1.93% $3.56 182K Jul 2, 2021 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MBRX Restricted Stock Units Options Exercise $0 -14.7K -2.01% $0.00 718K Jul 2, 2021 Common Stock 14.7K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units convert into common stock on a one-for-one basis.
F2 Shares withheld for payment of taxes upon vesting of restricted stock unit awards.
F3 On July 2, 2020, the reporting person was granted 58,869 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.